192 related articles for article (PubMed ID: 20030638)
1. Differential gene expression in drug hypersensitivity reactions: induction of alarmins in severe bullous diseases.
Bellón T; Alvarez L; Mayorga C; Morel E; Torres MJ; Martín-Díaz MA; Díaz R; Radial A; Carballo M; Blanca M
Br J Dermatol; 2010 May; 162(5):1014-22. PubMed ID: 20030638
[TBL] [Abstract][Full Text] [Related]
2. Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions.
Tapia B; Padial A; Sánchez-Sabaté E; Alvarez-Ferreira J; Morel E; Blanca M; Bellón T
J Allergy Clin Immunol; 2004 Aug; 114(2):335-40. PubMed ID: 15316512
[TBL] [Abstract][Full Text] [Related]
3. Expression of α-defensin 1-3 in T cells from severe cutaneous drug-induced hypersensitivity reactions.
Morel E; Alvarez L; Cabañas R; Fiandor A; Díaz R; Escamochero S; Prior N; Blanca M; Bellón T
Allergy; 2011 Mar; 66(3):360-7. PubMed ID: 20880148
[TBL] [Abstract][Full Text] [Related]
4. The innate immune system in delayed cutaneous allergic reactions to medications.
Bellón T; Blanca M
Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):292-8. PubMed ID: 21659858
[TBL] [Abstract][Full Text] [Related]
5. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
[TBL] [Abstract][Full Text] [Related]
6. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.
Ko TM; Chung WH; Wei CY; Shih HY; Chen JK; Lin CH; Chen YT; Hung SI
J Allergy Clin Immunol; 2011 Dec; 128(6):1266-1276.e11. PubMed ID: 21924464
[TBL] [Abstract][Full Text] [Related]
7. Activation of peripheral blood mononuclear cells and extracellular matrix and inflammatory gene profile in acute myocardial infarction.
Fang L; Du XJ; Gao XM; Dart AM
Clin Sci (Lond); 2010 May; 119(4):175-83. PubMed ID: 20388121
[TBL] [Abstract][Full Text] [Related]
8. Expression profiling of genes related to asthma exacerbations.
Aoki T; Matsumoto Y; Hirata K; Ochiai K; Okada M; Ichikawa K; Shibasaki M; Arinami T; Sumazaki R; Noguchi E
Clin Exp Allergy; 2009 Feb; 39(2):213-21. PubMed ID: 19187333
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling reveals a downregulation in immune-associated genes in patients with AS.
Duan R; Leo P; Bradbury L; Brown MA; Thomas G
Ann Rheum Dis; 2010 Sep; 69(9):1724-9. PubMed ID: 19643760
[TBL] [Abstract][Full Text] [Related]
10. Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation.
Moore DF; Li H; Jeffries N; Wright V; Cooper RA; Elkahloun A; Gelderman MP; Zudaire E; Blevins G; Yu H; Goldin E; Baird AE
Circulation; 2005 Jan; 111(2):212-21. PubMed ID: 15630028
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
12. Up-regulated perforin expression of CD8+ blood lymphocytes in generalized non-anaphylactic drug eruptions and exacerbated psoriasis.
Behrendt C; Gollnick H; Bonnekoh B
Eur J Dermatol; 2000; 10(5):365-9. PubMed ID: 10882944
[TBL] [Abstract][Full Text] [Related]
13. Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab.
Sekiguchi N; Kawauchi S; Furuya T; Inaba N; Matsuda K; Ando S; Ogasawara M; Aburatani H; Kameda H; Amano K; Abe T; Ito S; Takeuchi T
Rheumatology (Oxford); 2008 Jun; 47(6):780-8. PubMed ID: 18388148
[TBL] [Abstract][Full Text] [Related]
14. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption.
Kano Y; Hirahara K; Mitsuyama Y; Takahashi R; Shiohara T
Allergy; 2007 Dec; 62(12):1439-44. PubMed ID: 17983378
[TBL] [Abstract][Full Text] [Related]
15. Differences in immunological alterations and underlying viral infections in two well-defined severe drug eruptions.
Hirahara K; Kano Y; Mitsuyama Y; Takahashi R; Kimishima M; Shiohara T
Clin Exp Dermatol; 2010 Dec; 35(8):863-8. PubMed ID: 20456395
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome.
Okuyama S; Komatsuda A; Wakui H; Aiba N; Fujishima N; Iwamoto K; Ohtani H; Sawada K
Nephrol Dial Transplant; 2005 Mar; 20(3):539-44. PubMed ID: 15671071
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell apoptosis in severe drug-induced bullous eruptions.
Verneuil L; Ratajczak P; Allabert C; Leboeuf C; Comoz F; Janin A; Ameisen JC
Br J Dermatol; 2009 Dec; 161(6):1371-5. PubMed ID: 19575754
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiles of nasal polyps associated with allergic rhinitis.
Wu J; Bing L; Jin H; Jingping F
Am J Otolaryngol; 2009; 30(1):24-32. PubMed ID: 19027509
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of toxic epidermal necrolysis.
Lee MT; Hung SI; Wei CY; Chen YT
Expert Opin Pharmacother; 2010 Sep; 11(13):2153-62. PubMed ID: 20536296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
